Nucynta

 

Topic mentions per year

Topic mentions per year

2009-2015
01220092015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
INTRODUCTION Even though pain is a complex process involving many different mediators, enzymes, receptors and ion channels, pain… (More)
Is this relevant?
Review
2015
Review
2015
BACKGROUND Tapentadol (Nucynta) is indicated for the treatment of moderate to severe pain in adults. Tapentadol's mechanism of… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
2014
2014
Tapentadol (Nucynta) is a centrally acting opioid analgesic prescribed for the treatment of moderate to severe acute pain. Its… (More)
Is this relevant?
2014
2014
n engl j med 370;22 nejm.org may 29, 2014 2061 challenges of chronic pain and addiction. Chronic pain, which affects tens of… (More)
Is this relevant?
2013
2013
Abstract Since 2008, three new analgesic entities, tapentadol immediate release (Nucynta) diclofenac potassium soft gelatin… (More)
Is this relevant?
2010
2010
Urine specimens from pain management patients dosed with Nucynta (Tapentadol) were confirmed for the presence of tapentadol and N… (More)
Is this relevant?
2010
2010
330 P&T® • June 2010 • Vol. 35 No. 6 INTRODUCTION Widespread in the U.S., pain is associated with significant adverse economic… (More)
Is this relevant?
Review
2010
Review
2010
  • David S Craig
  • P & T : a peer-reviewed journal for formulary…
  • 2010
approved in the U.S., and they remain the primary alternatives to oxymorphone ER today. Some pain specialists do not consider LA… (More)
  • table 1
Is this relevant?
2009
2009
  • The Medical letter on drugs and therapeutics
  • 2009
The FDA has approved tapentadol hydrochloride (Nucynta--Ortho-McNeil Janssen) for oral treatment of moderate to severe acute pain… (More)
Is this relevant?
2009
2009
Analgesic Tapentadol hydrochloride (Nucynta—PriCara) is a centrally acting analgesic that acts via two mechanisms to relieve pain… (More)
Is this relevant?